Blog
892 Articles
Family, Friends, Hope, Strength, and Prayer
Susan Wells had chemotherapy but her treatment took a detour into more chemo and a clinical trial before she had a Whipple procedure.
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Tomorrow Is a New Day
Abby Pezzulo was an active young working mother when she was diagnosed with a pancreatic neuroendocrine tumor.
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
Learning to Recognize the Symptoms of Pancreatic Cancer
Recognizing the symptoms of pancreatic cancer is key to early detection. Laura Metzger’s story illustrates the importance of detecting pancreatic cancer early.
Evaluating Different Immunotherapy Combinations
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.
Let’s Win! Pancreatic Cancer Survivors Series—Year Five
Every year, long-term survivors share their inspiring stories about surviving pancreatic cancer and thriving after.
Claudin May Be the Next Big Target in Pancreatic Cancer Treatment
Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.
Vigilance Leads to Pancreatic Cancer Diagnosis
After his pancreatic cancer diagnosis, Michael Whalen searched for someone willing to treat him with chemotherapy.
Learn More About Qualifying for Clinical Trials
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
A Second Opinion Leads to Hope for the Future
Leanne Pierce decided to go to a major cancer center for a second opinion after her pancreatic cancer diagnosis.
I’m Still Here
As a five-year pancreatic cancer survivor, Angella Dixon-Watson considers it her mission to educate others about this disease.